Understand how treatment for primary chronic immune thrombocytopenia (ITP) in adults has evolved, hear current perspectives on the treatment of ITP in the COVID-19 era and look into the future with world-class experts
This CME-accredited symposium took place during the ISTH virtual congress on 14th July 2020.
The broader educational objectives of this programme are:
- Review of the current standard of care in ITP, detailing its risk and benefit
- Explain the mechanism of action and clinical data of potential new and innovative therapeutic options in ITP
- Comparison of standard of care today and in the future
The live event 'Current Perspectives on the Treatment of Primary Chronic ITP in Adults' took place during ISTH 2020 on 14th July 2020 and has been accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of External CME credits. Each participant should claim only those hours of credit that have actually been spent in the educational activity. Please note: CME credit can only be claimed for attending the live event on 14th July 2020.
Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credit™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website https://edhub.ama-assn.org/pages/applications. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.